IP Library Granted Patent US 6,994,956
Granted Patent B2
US 6,994,956 · App. 10/911,242 · Granted Feb 7, 2006

Method for assaying enzyme activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,994,956
App. No.
10/911,242
Granted
Feb 7, 2006
Kind
B2
Abstract

The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.

Claims (36)

1. A method for measuring enzyme activity of a reaction comprising

combining an enzyme and radiolabeled substrate(s);

adding a phase-partition scintillation fluid;

incubating the reaction for at least two hours; and

detecting enzyme activity,

wherein said reaction does not require mixing following addition of the phase-partition scintillation fluid and wherein said reaction is conducted in a single reaction vessel.

2. The method of claim 1 , further comprising

terminating the reaction by acidification.

3. The method of claim 1 , wherein the reaction is conducted in organic resistant multiwell plates.

4. The method of claim 3 , wherein the multiwell plate comprises up to 96 wells.

5. The method of claim 3 , wherein the multiwell plate comprises greater than 96 wells.

6. The method of claim 3 , wherein the multiwell plate comprises up to 384 wells.

7. The method of claim 3 , wherein the multiwell plate comprises greater than 384 wells.

8. The method of claim 1 , wherein said method is used for high throughput screening.

9. The method of claim 1 , wherein said enzyme is selected from fatty acid synthase; acetyl CoA carboxylase; diacyiglycerol acetyltransferase; farnesyl diphosphate synthase; glycerol-3-phosphate O-acyltransferase; carnitine O-palmitoyltransferase 1; serine C-palmitoyltransferase; or phospholipase C gamma.

10. The method of claim 1 , comprising measuring enzyme activity by radiometric detection.

11. The method of claim 1 , wherein enzyme activity is measured by incorporation of a radiolabel-containing moiety into product molecules or loss of a radiolabel-containing moiety into substrate molecules.

12. The method of claim 2 , wherein an acid is selected from acetic acid, phosphoric acid, or hydrochloric acid.

13. A method for identifying compounds that modulate enzyme activity in a reaction comprising

combining an enzyme, radiolabeled substrate(s) and test compounds;

adding a phase-partition scintillation fluid;

incubating the reaction for at least two hours; and

detecting enzyme activity,

wherein said reaction does not require mixing following addition of the phase-partition scintillation fluid and wherein said reaction is conducted in a single reaction vessel.

14. The method of claim 13 , further comprising

terminating the reaction by acidification.

15. The method of claim 13 , wherein the reaction is conducted in organic resistant multiwell plates.

16. The method of claim 15 , wherein the multiwell plate comprises up to 96 wells.

17. The method of claim 15 , wherein the multiwell plate comprises greater than 96 wells.

18. The method of claim 15 , wherein the multiwell plate comprises up to 384 wells.

19. The method of claim 15 , wherein the multiwell plate comprises greater than 384 wells.

20. The method of claim 13 , wherein said method is used for high throughput screening.

21. The method of claim 13 , wherein said enzyme is selected from fatty acid synthase; acetyl CoA carboxylase; diacylglycerol acetyltransferase; farnesyl diphosphate synthase; glycerol-3-phosphate O-acyltransferase; camitine O-palmitoyltransferase 1; serine C-palmitoyltransferase; or phospholipase C gamma.

22. The method of claim 13 , comprising measuring enzyme activity by radiometric detection.

23. The method of claim 13 , wherein enzyme activity is measured by incorporation of a radiolabel-containing moiety into product molecules or loss of a radiolabel-containing moiety into substrate molecules.

24. The method of claim 14 , wherein an acid is selected from acetic acid, phosphoric acid, or hydrochloric acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023027/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2004
From: LANDRO, JAMES A.; PICKETT, WALTER; OSTERMAN, DAVID G.
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 015413/0220 →